Product logins

Find logins to all Clarivate products below.


Neurostimulation Devices – Market Insights – Europe (Supplemental)

The European neurostimulation market will grow modestly through 2033. Growth in this market is largely driven by product innovations, particularly in the SCS and DBS segments, and iterative improvements introduced by competitors in various market segments. However, competition from noninvasive technologies, strict patient selection criteria, and limited reimbursement will limit market growth to some extent.

This Medtech 360 Report provides high-level market metrics for neurostimulation devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe
The European large-joint reconstructive implant market is poised for long-term sustained growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants,…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…